N4-Benzoylcytosine CAS 26661-13-2 Ubunyulu ≥99.0% Sofosbuvir Intermediate Factory
Igama | N4-Benzoylcytosine |
Inombolo yeCAS | 26661-13-2 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C11H9N3O2 |
Ubunzima beMolekyuli | 215.21 |
Ukuxinana | 1.33±0.10 g/cm3 |
Indawo yokunyibilika | >300℃(dec.) (lit.) |
I-COA kunye ne-MSDS | Iyafumaneka |
Imvelaphi | Shanghai, China |
Beka ubomi kwishelufa | Iinyanga ezingama-36 ukuba zigcinwe ngokufanelekileyo |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe okanye oMhlophe |
Ukuchongwa | HPLC |
Ubunyulu / Indlela yokuHlalutya | ≥99.0% (HPLC) |
Ukufuma (KF) | ≤0.50% |
Ilahleko ekomisweni | ≤0.50% |
Intsalela kwi-Ignition | ≤0.50% |
Cytosine | ≤0.50% |
Iintsimbi ezinzima | ≤20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Isicelo | Umbindi weSofosbuvir (CAS: 1190307-88-0) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma
Iimpawu zeHazard Xi - Irritant
IiKhowudi zoMngcipheko R20/22 - Zinobungozi ngokuphefumla umoya kwaye ukuba uginyiwe.
R36/37/38 - Ukucaphukisa emehlweni, inkqubo yokuphefumla kunye nolusu.
Inkcazelo yoKhuseleko
S26 - Xa udibana namehlo, hlambulula ngokukhawuleza ngamanzi amaninzi kwaye ufune iingcebiso zonyango.
S36 - Nxiba iimpahla ezifanelekileyo zokukhusela.
WGK eJamani 3
Ikhowudi yeHS 2933599099
I-Sofosbuvir (i-CAS: i-1190307-88-0) ichiza elisetyenziselwa unyango lwe-hepatitis C. Kucetyiswa ukuba isetyenziswe ngokudibanisa nezinye iziyobisi (ezifana ne-velpatasvir) kunyango lokuqala lwe-HCV genotypes 1, 2, I-3, i-4, i-5, kunye ne-6. Isebenza ngokusebenza njenge-nucleotide analog inhibitor, ekwazi ukuthintela ngokukodwa i-HCV NS5B (i-protein engeyiyo i-5B) exhomekeke kwi-RNA polymerase.I-sofosbuvir yomlomo yayinyamezeleke kakuhle kwizigulana ezine-hepatitis C engapheliyo.